[1]傅琪琳,黄甫,李粉萍,等.鼓胀退水贴对肝硬化腹水患者门静脉血流动力学及生活质量的影响[J].西部中医药,2025,38(04):131-133.[doi:10.12174/j.issn.2096-9600.2025.04.26]
 FU Qilin,HUANG Fu,LI Fenping,et al.Influence of Tympanites Ascites-eliminating Plaster on Quality of Life and Portal Vein Hemodynamics in Patients with Cirrhotic Ascites[J].Western Journal of Traditional Chinese Medicine,2025,38(04):131-133.[doi:10.12174/j.issn.2096-9600.2025.04.26]
点击复制

鼓胀退水贴对肝硬化腹水患者门静脉血流动力学及生活质量的影响()
分享到:

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
38
期数:
2025年04期
页码:
131-133
栏目:
特色医疗
出版日期:
2025-04-15

文章信息/Info

Title:
Influence of Tympanites Ascites-eliminating Plaster on Quality of Life and Portal Vein Hemodynamics in Patients with Cirrhotic Ascites
作者:
傅琪琳, 黄甫, 李粉萍, 唐颖慧, 王亚娟, 王红, 薛敬东
陕西省中医医院,陕西 西安 710002
Author(s):
FU Qilin, HUANG Fu, LI Fenping, TANG Yinghui, WANG Yajuan, WANG Hong, XUE Jingdong
Shaanxi Provincial TCM Hospital, Xi’an 710002, China
关键词:
肝硬化腹水鼓胀退水贴穴位贴敷门静脉生活质量
Keywords:
cirrhosisascitestympanites ascites-eliminating plasteracupoint applicationportal veinquality of life
分类号:
R256.42
DOI:
10.12174/j.issn.2096-9600.2025.04.26
文献标志码:
B
摘要:
目的观察鼓胀退水贴对肝硬化腹水患者门静脉血流动力学和生活质量的影响。 方法将100例肝硬化腹水患者按照就诊顺序分成观察组和对照组,每组50例。两组均给予常规保肝、利尿治疗,观察组在常规治疗基础上,给予鼓胀退水贴外敷,共治疗3周。观察两组腹水消退情况、门静脉血流动力学变化及生活质量评分变化。 结果总有效率观察组[86%(43/50)]高于对照组[74%(37/50)](P<0.05)。治疗后两组患者门静脉内径差异无统计学意义(P>0.05),而两组患者门静脉血流速度、门静脉血流量均较治疗前降低(P<0.05),且观察组均低于对照组(P<0.05)。治疗后两组患者生理功能、生理职能、总体健康、活力、情感职能、精神健康评分均高于治疗前(P<0.05),且观察组生理功能、总体健康、活力、精神健康评分均明显高于对照组(P<0.05)。 结论鼓胀退水贴可加速腹水消退,能在一定程度上改善患者生活质量,而其治疗肝硬化腹水的机制可能在于控制门静脉血流速度,减少门静脉血流灌注,从而降低门静脉压力。
Abstract:
ObjectiveTo explore the influence of tympanites ascites-eliminating plaster on portal vein hemodynamics and quality of life in patients with cirrhotic ascites. MethodsAll 100 patients were randomized into the observation group and the control group with 50 cases in each group. Both groups accepted conventional liver protection and diuretic therapy, the observation group accepted external application of tympanites ascites-eliminating plaster on the foundation of conventional treatment, for three weeks. To observe the elimination conditions of ascites, portal vein hemodynamics and the scores of quality of life between both groups. ResultsTotal effective rate of the observation group was [86%(43/50)], higher than [74%(37/50)] of the control group (P<0.05). The difference had no statistical meaning in portal vein diameter between the two groups after the treatment (P>0.05), while portal venous blood flow velocity and portal venous blood flow were lower than before the treatment (P<0.05), and the observation group was lower than the control group (P<0.05). After the treatment, the scores of physiologic function, physiological role, overall health status, vigor, emotional role and mental health of the two groups were higher than before the treatment (P<0.05), and the scores of physiologic function, overall health status, vigor and mental health of the observation group were obviously higher than these of the control group (P<0.05). ConclusionTympanites ascites-eliminating plaster could accelerate the elimination of ascites, improve the patients’ quality of life to a certain extent, and the mechanism of treating cirrhotic ascites might be related to controlling portal venous blood flow velocity and reducing portal venous blood flow perfusion, thereby reducing portal vein pressure.

相似文献/References:

[1]黄鸿娜,黄晶晶△,王振常,等.柔肝化纤颗粒治疗肝硬化脾功能亢进症的临床观察[J].西部中医药,2014,27(09):111.
[2]谷雨.刘沈林教授运用健脾化瘀法治疗癌性腹水验案举隅[J].西部中医药,2014,27(12):31.
[3]张萍,朱建坤.肝硬化患者应用中医食疗的临床护理分析[J].西部中医药,2013,26(07):112.
 ZHANG Ping,ZHU Jiankun.Analysis on Clinical Nursing for Liver Cirrhosis Patients Given with TCM Food Therapy[J].Western Journal of Traditional Chinese Medicine,2013,26(04):112.
[4]刘建军,曾贤翠,郝淑萍,等.腹水超滤浓缩回输联合中医辨证治疗肝硬化顽固性腹水40例临床观察[J].西部中医药,2013,26(06):1.
 LIUJianjun,ZENGXiancui,HAOShuping,et al.ClinicalObservationonUltrafiltrationReinfusionofConcentratedAscitesandSyndromeDifferentiationforRefractoryAscitesofLiverCirrhosis:AReportof40Cases[J].Western Journal of Traditional Chinese Medicine,2013,26(04):1.
[5]樊红,冯彦虎,张德奎△,等.中西医结合治疗肝炎后肝硬化腹水疗效观察[J].西部中医药,2013,26(02):91.
 FAN Hong,FENG Yanhu,ZHANG Dekui,et al.Clinical Observation on Integrative Medicine in Treating Cirrhosis Ascites of Patients with Hepatitis[J].Western Journal of Traditional Chinese Medicine,2013,26(04):91.
[6]闫雪华.恩替卡韦联合复方鳖甲软肝片治疗代偿期乙肝肝硬化疗效观察[J].西部中医药,2014,27(07):84.
 YAN Xuehua.Clinical Observation on Entecavir Combined with Compound BieJia RuanGan Tablets in Treating Decompensated Liver Cirrhosis of Hepatitis B[J].Western Journal of Traditional Chinese Medicine,2014,27(04):84.
[7]龚红霞,邱晶.多层螺旋CT门静脉成像在肝硬化中医证型诊断中的应用价值[J].西部中医药,2018,31(12):147.
 GONG Hongxia,QIU Jing.Application Value of Multilayer Spiral CT Portal Vein Imaging in the Diagnosis of TCM Patterns of Liver Cirrhosis[J].Western Journal of Traditional Chinese Medicine,2018,31(04):147.
[8]朱艳国,朱艳丽△,张金花.自拟化积膏治疗肝硬化疗效观察[J].西部中医药,2019,32(05):63.
 ZHU Yanguo,ZHU Yanli,ZHANG Jinhua.Clinical Observation on Selfmade HuaJi Ointment in Treating Cirrhosis[J].Western Journal of Traditional Chinese Medicine,2019,32(04):63.
[9]陈美岑,等.柔肝化纤颗粒对失代偿期肝硬化患者肠道菌群的影响[J].西部中医药,2021,34(12):99.[doi:10.12174/j.issn.2096-9600.2021.12.26]
 CHEN Meicen,WANG Zhenchang,et al.Effects of Rougan Huaxian Granules on Intestinal Flora in Patients with Decompensated Cirrhosis[J].Western Journal of Traditional Chinese Medicine,2021,34(04):99.[doi:10.12174/j.issn.2096-9600.2021.12.26]
[10]马玉珍,毛德文,覃艳新,等.六味醒神颗粒治疗肝硬化轻微型肝性脑病的临床疗效及其对血氨和内毒素的影响[J].西部中医药,2021,34(05):7.[doi:10.12174/j.issn.2096-9600.2021.05.03]
 MA Yuzhen,MAO Dewen,QIN Yanxin,et al.Clinical Effects of Liuwei Xingshen Granules in Treating Mild Hepatic Encephalopathy of Liver Cirrhosis and Its Influence on Blood Ammonia and Endotoxin[J].Western Journal of Traditional Chinese Medicine,2021,34(04):7.[doi:10.12174/j.issn.2096-9600.2021.05.03]
[11]徐婷婷,安振涛,李慧,等.肝硬化腹水证治分布及脐敷疗法用药规律文献研究[J].西部中医药,2021,34(06):85.[doi:10.12174/j.issn.2096-9600.2021.06.20]
 XU Tingting,AN Zhentao,LI Hui,et al.Literature Study on the Distribution of Syndrome Differentiation and Treatment of Cirrhosis Ascites and Medication Rules of Umbilical Compressing Therapy[J].Western Journal of Traditional Chinese Medicine,2021,34(04):85.[doi:10.12174/j.issn.2096-9600.2021.06.20]

备注/Memo

备注/Memo:
傅琪琳(1984—),女,博士学位,副主任医师。研究方向:中医药防治慢性肝胆疾病。陕西省自然科学基础研究计划(2019JQ-981)。
更新日期/Last Update: 2025-04-15